Additional pledge of 26.21 lakh Ajanta Pharma shares by promoter group

Ownership Changes View source PDF Explain this filing

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹3592.60

prior close

₹3548.40

announcement price

In-mkt

timing

Nifty Midcap 150market-1.0%+0.8% vs market

Pharmaceuticals peers, median of 173sector-0.8%+0.6% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Midcap 150 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-1.0+0.8-0.8+0.6

Next day

-2.6-0.5-2.1-1.2-1.4

-0.9+0.5-1.4-0.4-0.5

-0.2-0.1-0.1-0.1-0.1

-4.4-2.5-1.8-3.0-1.4

-5.2-1.2-4.0-3.1-2.1

-7.6-0.2-7.4-3.0-4.6

15d

-5.1-4.8-0.3-7.1+2.0

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CTL Trusteeship received an additional pledge of 26,21,067 Ajanta Pharma shares (2.10 percent) from promoter group entities including Aayush Agrawal Trust, Aayush Agrawal, and Gabs Investments. The pledge secures secured unlisted redeemable non-convertible debentures of up to Rs 3,373 crore by Lenexis Foodworks and Rs 500 crore by Inspira Realty 2. Post-pledge, total pledged shares stand at 92,53,718 (7.41 percent) and total encumbered shares at 1,63,32,924 (13.53 percent).

Likely market impact

Higher encumbrance on promoter shares; investors should monitor for any pledge invocation or governance risks.